Revenue | 4Q2016 | 4Q2015 | Change | FY2016 | FY2015 | Change |
US$'000 | US$'000 | US$'000 | US$'000 | |||
Restated* | Restated* | |||||
11,947,192 | 9,431,171 | 26.7% | 41,401,690 | 38,776,635 | 6.8% | |
Net Profit | 560,772 | 330,150 | 69.9% | 972,245 | 1,022,925 | -5.0% |
Core Net Profit | 589,501 | 346,554 | 70.1% | 976,604 | 1,136,415 | -14.1% |
EBITDA | 845,730 | 613,838 | 37.8% | 2,244,494 | 2,100,532 | 6.9% |
EPS - Basic (US cents per share) | 8.9 | 5.2 | 71.2% | 15.4 | 16.1 | -4.3% |
EPS - Fully diluted (US cents per share) | 8.9 | 5.2 | 71.2% | 15.4 | 16.1 | -4.3% |
Net Tangible Asset (US$'000) Net Asset per share (US$ per share) Net Tangible Asset per share (US$ per share) | 31.12.2016 | 31.12.2015 Restated* | Change | |||
10,068,798 | 10,025,279 | 0.4% | ||||
2.29 | 2.28 | 0.4% | ||||
1.59 | 1.59 | 0.0% |
*Prior period figures were restated upon adoption of Amendments to FRS 16 Property, Plant and Equipment and FRS 41 Agriculture: Bearer Plants
1(a)(i) Consolidated Income StatementGroup | Group | |||||
Three months ended | Twelve months ended | |||||
31.12.2016 US$'000 | 31.12.2015 US$'000 Restated* | Change | 31.12.2016 US$'000 | 31.12.2015 US$'000 Restated* | Change | |
Revenue Cost of sales | 11,947,192 (10,523,336) | 9,431,171 (8,343,549) | 26.7% -26.1% | 41,401,690 (37,391,071) | 38,776,635 (34,867,211) | 6.8% -7.2% |
Gross profit | 1,423,856 | 1,087,622 | 30.9% | 4,010,619 | 3,909,424 | 2.6% |
Other items of income | ||||||
Net loss arising from changes in fair | ||||||
value of biological assets | (16,047) | (15,552) | -3.2% | (16,047) | (15,552) | -3.2% |
Finance income | 46,391 | 95,450 | -51.4% | 191,619 | 470,527 | -59.3% |
Other operating income | 67,028 | 37,902 | 76.8% | 157,953 | 139,396 | 13.3% |
Other items of expense | ||||||
Selling and distribution expenses | (483,151) | (444,782) | -8.6% | (1,806,434) | (1,677,771) | -7.7% |
Administrative expenses | (178,075) | (173,994) | -2.3% | (680,675) | (696,461) | 2.3% |
Other operating expenses | (225,287) | (133,556) | -68.7% | (359,271) | (315,756) | -13.8% |
Finance costs | (85,764) | (97,269) | 11.8% | (348,531) | (444,176) | 21.5% |
Non-operating items | (18,715) | 1,490 | n.m. | 9,844 | (94,953) | n.m. |
Share of results of joint ventures | (441) | 3,621 | n.m. | (11,682) | (6,673) | -75.1% |
Share of results of associates | 68,017 | 57,860 | 17.6% | 152,558 | 111,337 | 37.0% |
Profit before tax | 597,812 | 418,792 | 42.7% | 1,299,953 | 1,379,342 | -5.8% |
Income tax expense | 23,348 | (58,744) | n.m. | (206,294) | (281,993) | 26.8% |
Profit after tax | 621,160 | 360,048 | 72.5% | 1,093,659 | 1,097,349 | -0.3% |
Owners of the Company | 560,772 | 330,150 | 69.9% | 972,245 | 1,022,925 | -5.0% |
Non-controlling interests | 60,388 | 29,898 | 102.0% | 121,414 | 74,424 | 63.1% |
621,160 | 360,048 | 72.5% | 1,093,659 | 1,097,349 | -0.3% |
*Prior period figures were restated upon adoption of Amendments to FRS 16 Property, Plant and Equipment and FRS 41 Agriculture: Bearer Plants
n.m. - not meaningful
1(a)(ii) Consolidated Statement of Comprehensive IncomeGroup | Group | |||||
Three months ended | Twelve months ended | |||||
31.12.2016 US$'000 | 31.12.2015 US$'000 Restated* | Inc/(Dec) US$'000 | 31.12.2016 US$'000 | 31.12.2015 US$'000 Restated* | Inc/(Dec) US$'000 | |
Profit after tax | 621,160 | 360,048 | 261,112 | 1,093,659 | 1,097,349 | (3,690) |
Other comprehensive income | (389,577) | (54,054) | (335,523) | (498,608) | (834,223) | 335,615 |
- Items that may be reclassified subsequently to | ||||||
income statement | ||||||
Foreign currency translation | ||||||
Fair value adjustment on cash flow hedges | (11,754) | 17,536 | (29,290) | (45,613) | (111,703) | 66,090 |
Fair value adjustment on available-for-sale financial | ||||||
assets | (26,481) | (9,498) | (16,983) | (14,033) | 43,647 | (57,680) |
Share of changes in equity transaction reserve of an | ||||||
associate | (10,557) | - | (10,557) | (10,557) | - | (10,557) |
(438,369) | (46,016) | (392,353) | (568,811) | (902,279) | 333,468 | |
- Item that will not be reclassified subsequently to | (4,500) | (9,824) | 5,324 | (4,500) | (9,824) | 5,324 |
income statement | ||||||
Loss on remeasurements of defined benefit plan | ||||||
(4,500) | (9,824) | 5,324 | (4,500) | (9,824) | 5,324 | |
Total other comprehensive income, net of tax | (442,869) | (55,840) | (387,029) | (573,311) | (912,103) | 338,792 |
Total comprehensive income | 178,291 | 304,208 | (125,917) | 520,348 | 185,246 | 335,102 |
Owners of the Company | 142,852 | 291,152 | (148,300) | 436,919 | 159,551 | 277,368 |
Non-controlling interests | 35,439 | 13,056 | 22,383 | 83,429 | 25,695 | 57,734 |
178,291 | 304,208 | (125,917) | 520,348 | 185,246 | 335,102 |
*Prior period figures were restated upon adoption of Amendments to FRS 16 Property, Plant and Equipment and FRS 41 Agriculture: Bearer Plants
1(b)(i) Balance SheetsGroup | Company | ||||
31.12.2016 US$'000 | 31.12.2015 US$'000 Restated* | 01.01.2015 US$'000 Restated* | 31.12.2016 US$'000 | 31.12.2015 US$'000 | |
ASSETS | 8,297,098 | 8,983,482 | 9,477,284 | 2,389 | 1,485 |
Non-current assets | |||||
Property, plant and equipment | |||||
Bearer plants | 726,725 | 742,282 | 796,252 | - | - |
Plasma investments | 17,393 | 14,721 | 12,829 | - | - |
Intangible assets | 4,365,736 | 4,368,860 | 4,401,908 | - | - |
Investment in subsidiaries | - | - | - | 9,072,026 | 9,004,098 |
Investment in joint ventures | 940,287 | 874,980 | 355,185 | 205,886 | 231,396 |
Investment in associates | 1,963,123 | 1,856,422 | 1,770,045 | 40,444 | 41,347 |
Available-for-sale financial assets | 700,705 | 650,042 | 592,245 | - | - |
Deferred tax assets | 312,403 | 198,116 | 203,808 | - | - |
Derivative financial instruments | 32,633 | 2,786 | 15,172 | - | - |
Other financial receivables | 205,832 | 334,552 | 293,974 | 399,634 | 351,373 |
Other non-financial assets | 34,869 | 33,171 | 31,489 | - | - |
17,596,804 | 18,059,414 | 17,950,191 | 9,720,379 | 9,629,699 | |
Current assets | 7,022,310 | 6,317,534 | 6,581,020 | - | - |
Inventories | |||||
Trade receivables | 4,087,069 | 3,752,720 | 4,044,799 | - | - |
Other financial receivables | 2,354,502 | 2,898,826 | 3,995,132 | 3,399,383 | 3,354,424 |
Other non-financial assets | 1,152,019 | 1,253,509 | 1,478,001 | 342 | 1,622 |
Derivative financial instruments | 546,885 | 567,221 | 755,826 | - | - |
Biological assets | 49,439 | 65,486 | 81,038 | - | - |
Financial assets held for trading | 316,632 | 304,694 | 261,470 | - | - |
Other bank deposits | 2,721,885 | 2,410,281 | 5,452,091 | - | - |
Cash and bank balances | 1,184,881 | 1,296,316 | 1,947,096 | 4,057 | 1,374 |
19,435,622 | 18,866,587 | 24,596,473 | 3,403,782 | 3,357,420 | |
TOTAL ASSETS | 37,032,426 | 36,926,001 | 42,546,664 | 13,124,161 | 12,987,119 |
*Prior year figures were restated upon adoption of Amendments to FRS 16 Property, Plant and Equipment and FRS 41 Agriculture: Bearer Plants
Wilmar International Limited published this content on 20 February 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 20 February 2017 10:32:01 UTC.
Original documenthttp://media.corporate-ir.net/media_files/IROL/16/164878/Wilmar-4QFY2016-Financial-Results-Announcement.pdf
Public permalinkhttp://www.publicnow.com/view/E897F55A2A917704CF1EC26189A9E661DE1E2FA9